(19)
(11) EP 3 648 782 A2

(12)

(88) Date of publication A3:
29.08.2019

(43) Date of publication:
13.05.2020 Bulletin 2020/20

(21) Application number: 18902238.7

(22) Date of filing: 05.07.2018
(51) International Patent Classification (IPC): 
A61K 36/38(2006.01)
 A61P 35/00(2006.01)
(86) International application number:
PCT/TR2018/050348
(87) International publication number:
WO 2019/147195 (01.08.2019 Gazette 2019/31)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 05.07.2017 TR 201709895

(71) Applicant: Anadolu Universitesi
26470 Eskisehir (TR)

(72) Inventors:
  • SIVAS, Hulya
    Anabilim Dali, Eskisehir (TR)
  • KARAOSMANOGLU, Oguzhan
    Anabilim Dali Tepebas /Eskisehir (TR)
  • KUETE, Victor
    Bafoussam (CM)

(74) Representative: Sevinç, Cenk 
Grup Ofis Marka Patent A.S. Ataturk Bulvari 211/11 Kavaklidere
06680 Ankara
06680 Ankara (TR)

   


(54) USE OF FERRUGININ A (FGA) COMPOUND AS A CHEMOTHERAPEUTIC GENT AND MAPK PATHWAY INHIBITOR DUE TO BIOLOGICAL ACTIVITY THEREOF